Table 2.
CHEMO trials | Component | Median survival | P value |
GERCORD/GISCAD[66] | Gem ± oxaliplatin | 9.0 mo vs 7.1 mo | 0.13 |
Van Cutsem et al[67] | Gem ± tipifarnib | 193 d vs 182 d | 0.75 |
IRINOGEM[68] | Gem ± irinotecan | 6.3 mo vs 6.6 mo | 0.79 |
Von Hoff et al[69] | Gem ± nab-paclitaxel | 8.5 mo vs 6.7 mo | < 0.001 |
PRODIGE[70] | Gem vs FOLFIRINOX | 6.8 mo vs 11.1 mo | < 0.001 |
CHEMO: Chemotherapy; Gem: Gemcitabine.